Clinical applications of proton magnetic resonance spectroscopy of the brain;Klinische Anwendungen der Protonen-Magnetresonanzspektroskopie des Gehirns

RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren

Volumn 168, Issue 6, 1998, Pages 539-549

  Laubenberger, J ^a,b   Bayer, S ^a   Thiel, T ^a   Hennig, J ^a   Langer, M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NONE   (Germany)

Author keywords

Hepatic encephalopathy; HIV encephalopathy; Leucoencephalopathy; Magnetic resonance; Proton MR spectroscopy

Indexed keywords

CHOLINE; CREATINE; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

ALZHEIMER DISEASE; BRAIN DISEASE; BRAIN RADIOGRAPHY; CONSCIOUSNESS DISORDER; EPILEPSY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CIRRHOSIS; METABOLITE; PEDIATRICS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW;

AIDS DEMENTIA COMPLEX; ALZHEIMER DISEASE; ANIMALS; ASPARTIC ACID; BRAIN; BRAIN DISEASES; BRAIN DISEASES, METABOLIC; CHILD; CHOLINE; CREATINE; GLUTAMINE; HEPATIC ENCEPHALOPATHY; HUMANS; INOSITOL; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROTONS; RATS;

EID: 0031815968     PISSN: 09366652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Bottomley PA. Spatial localization in NMR-spectroscopy in vivo. Proc NY Acad Sci 1987; 508: 333-348
2. Frahm J, Merboldt KD, Haenicke W. Localized proton spectroscopy using stimulated echoes. J Magn Reson Med 1987; 72: 502
3. Hennig J, Pfister H. Ernst T, Ott D. Direct absolute quantification of metabolites in the human brain with in vivo localized proton spectroscopy. NMR in Biomed 1992; 6: 193-199
4. Miller BL. A review of chemical issues in 1 H NMR Spectroscopy: N-Acetyl-L-Aspartate, creatine and cholin. NMR in Biomed 1991; 4: 47-52
5. Chamuleau RA, Bosman DK, Bovée WM. Luyten PR, den Hollander JA. What the clinician can learn from MR glutamine/ glutamate assays. NMR in Biomed 1991; 4, 103-108
6. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Mag Res Med 1993; 30: 424-437
7. Chang L Ernst T, Poland RE, Jenden DJ. In vivo proton magnetic resonance spectroscopy of the normal aging human brain. Life Sciences 1996; 58: 2049-2056
8. Tallan HH. Studies on the distribution of N-acetyl-L-aspartic acid in brain. J Biol Chem 1956; 224: 41-45
9. Koller KJ, Zaczek R, Coyle J. N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem 1984; 43: 1136-1142
10. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1: 623-634
11. Arnold DL, Matthews PM, Francis G, Antel J. Proton magnetic resonance spectroscopy of human brain in-vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn Reson Med 1990; 14: 154-159
12. Miller BL. A Review of chemical issues in 1 H NMR Spectroscopy: N-Acetyl-Aspartate, creatine and choline. NMR in Biomed 1991; 4: 47-52
13. Richards TL. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. AJR 1991; 157: 1073-1078
14. Jope RS, Jenden DJ. Choline and phospholipid metabolism and synthesis of acetylcholine in rat brain. J Neurosci Res 1979; 4: 69-82
15. Häussinger D, Laubenberger J, vom Dahl S, Ernst Th, Bayer S, Langer M, Gerok W, Hennig J. Proton magnetic resonance spectroscopic studies on human brain myo-Inositol in hypoosmolarity and hepatic encephalopathy. Gastroenterology 1994; 107: 145-148
16. Bruhn H, Michaelis T, Merboldt KD, Hänicke W, Gyngell ML, Hamburger C, Frahm J. On the interpretation of NMR spectra from brain tumors in vivo and in vitro. NMR in Biomed 1992; 5: 253-258
17. Ott D, Hennig J, Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 1993; 186: 745-752
18. Speck O, Thiel T, Hennig J. Grading and therapy monitoring of astrocytomas with 1 H spectroscopy: preliminary study. Anticancer Research 1996; 16: 1581-1585
19. Ernst T, Hennig J, Ott D, Friedburg H. The importance of the voxel size in clinical 1 H spectroscopy of the human brain. NMR in Biomed 1989; 5/6: 216-224
20. Wald LL, Moyher SE, Day MR, Nelson SJ, Vigneron DB. Proton spectroscopic imaging of the human brain using phased array detectors. Magnetic Resonance in Medicine 1995; 34: 440-445
21. Nelson SJ, Day MR, Henry R, Wald LL, Noworolski SM, Star-Lack JM, Dillon WP, Vigneron DB. Differences between anatomic and metabolic abnormalities associated with primary brain tumors as assessed by gadolinium enhanced MRI and 3-D proton MR spectroscopic imaging. ISMRM Proceedings. Berkeley 1997: 1112
22. Preul MC, Caramanos Z, Collins DL, Villemure JG, Leblanc R, Olivier A, Pokrupa R, Arnold DL. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nature Medicine 1996; 2: 323-325
23. Chang L, Miller BL, McBride D, Cornford M, Oropilla G, Buchthal S, Chiang F, Aronow H, Ernst T. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995; 197: 525-531
24. Arnold DL, Matthews PM, Francis G, Antel J. Proton Magnetic Resonance Spectroscopy of human brain in-vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn Reson Med 1990; 14: 154-159
25. Koopmans RA, Li DK, Zhu G, Allen PS, Penn A, Paty DW. Magnetic resonance spectroscopy of multiple sclerosis: in-vivo detection of myelin breakdown products. The Lancet 1993; 341: 631-632
26. Davie CA, Hawkins CP, Barker GJ, Brennan A, Tofts PS, Miller DH, McDonald WI. Detection of myelin breakdown products by proton magnetic resonance spectroscopy. Lancet 1993; 341: 630-631
27. Valck J, van der Knaap M. Normal myelination and myelin disorders. Springer 1993
28. Grodd W, Krägelin-Mann I, Klose U, Sauter R. Metabolic and destructive disorders in children: findings with localized proton spectroscopy. Radiology 1991; 181: 173-181
29. Wittsack HJ Kugel H, Roth B, Heindel W. Quantitative measurements with localized 1 H MR spectroscopy with Canavan's disease. J Magn Reson Imag 1996; 6: 889-993
30. Reye RDK, Miorgan G, Baral J. Encephalopathy and fatty degeneration of the viscera, a disease entity in childhood. Lancet 1963; 11: 749-752
31. Kreis R, Pfenninger J, Herschkowitz N, Boesch C. In vivo proton magnetic resonance spectroscopy in a case of Reye's syndrome. Intensive Care Medicine 1995; 21: 266-269
32. Pietz J, Kreis R, Schmidt H, Meyding-Lamade UK, Rupp A, Boesch C. Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment. Radiology 1996; 201: 413-420
33. Krageloh-Mann I, Grodd W, Schoning M, Marquard K, Nagele T, Ruitenbeek W. Proton spectroscopy in five patients with Leigh's disease and mitochondrial enzyme deficiency. Developmental Medicine & Child Neurology 1993; 35: 769-776
34. Castillo M, Kwock L, Green C. MELAS syndrome: imaging and proton MR spectroscopic findings. Amer J Neuroradiol 1995; 16: 233-239
35. Lu D, Margouleff C, Rubin E, Labar D, Schaul N, Ishikawa T, Kazumata K, Antonini A, Dhawan V, Hyman RA, Eidelberg D. Temporal lobe epilepsy: correlation of proton magnetic resonance spectroscopy and 18 F-fluorodeoxyglucose positron emission tomography. Magn Res Med 1997; 37: 18-23
36. Ende GR Laxer KD, Knowlton RC, Matson GB, Schuff N, Fein G, Weiner MW. Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging. Radiology 1997; 202: 809-817
37. Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased cerebral myo-Inositol with proton MR spectroscopy. Radiology 1993: 187: 433-437
38. Moats RA, Ernst T, Truda KS, Ross BD. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Res Med 1994: 32: 110-115
39. Everall IP, Luthert PJ, Lantos PL. Neuronal loss in the frontal cortex in HIV infection. Lancet 1991; 337: 1119-1121
40. Meyerhoff DJ, MacKay S, Bachman L, Poole N, Dillon W, Fein CM, Weiner M. Reduced brain N-Acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1 H magnetic resonance spectroscopic imaging. Neurology 1993; 43: 509-515
41. Jarvik JC, Lenkinski RE, Grossman RI, Gomon JM, Schnall MD, Frank I. Proton MR spectroscopy of HIV infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology 1993; 186: 739-744
42. Chong WK, Sweeney B, Wilkonson ID, Paley M, Hali-Craggs MA, Kendall BE, Shepard M, Beecham RF, Miller RF, Weller SP, Newman SP, Harrison MJ. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology 1993; 188: 119-124
43. Vion-Dury S, Confort-Gouny M, Nicoli F,. Dhiver C, Gastaut JA, Gastaut JL, Cozzone PJ. Localized brain proton MRS metabolic patterns in HIV-related encephalopathies. CR Acad Sci Paris 1994; 317: 833-840
44. Laubenberger J, Haussinger D, Bayer S, Thielemann S, Schneider B, Mundinger A, Hennig J, Langer M. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology 1996; 199: 805-810
45. Everall IP, Luthert PJ, Lantos PL. Neuronal loss in the frontal cortex in HIV infection. Lancet 1991; 337: 1119-1121
46. Lang F, Ritter M, Völkl H, Häussinger D. The biological significance of cell volume. Renal Physiol Biochem 1993; 16: 48-65
47. Sterns R, Baer J, Ebersol S, Thomas D, Lohr JW, Kamm DE. Organic osmolytes in acute hyponatremia. Amer J Phys 1993; 264: 833-836
48. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Developmental Neuroscience 1993; 15: 289-298
49. Ferenci P, Püspök A, Steindl P. Current concepts in the pathophysiology of hepatic encephalopathy. Eur J Clin Inv 1992; 22: 573-581
50. Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with 1 H MR spectroscopy. Radiology 1992; 182: 19-27
51. Gupta RK, Saraswat VA, Poptani H, Dhiman RK, Kohli A, Gujral RB, Naik SR Magnetic
52. Ross Bd, Jacobson S, Villamil F, Korula J, Kreis R, Ernst T, Shonk T, Moats R. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994; 193: 457-463
53. Geissler A, Lock G, Frund R, Held P, Hollerbach S, Andus T, Schölmerich J, Feuerbach S, Holstege A. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic reso-nance spectroscopy and magnetic resonance imaging. Hepatology 1995; 25: 48-54
54. Laubenberger J, Häussinger D, Bayer S, Gufler H, Hennig J, Langer M. Demonstration of cerebral metabolic abnormalities in asymptomatic patients with liver cirrhosis by Proton MR spectroscopy. Gastroenterology 1997; 112: 1610-1618
55. Geissler A, Frund R, Kohler S, Eichhorn HM, Kramer BK, Feuerbach S. Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy. Radiology 1995; 194: 693-697
56. Kreis R, Ross BD. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 1992; 184: 123-130
57. 1H MR spectroscopy (MRS) in Diabetic Patients. Berkeley: Proc Intern Soc Magn Reson Med, 1997: 1238
58. Häussinger D, Laubenberger J, v. Dahl S, Ernst T, Bayer S, Langer M, Gerok W, Hennig J. Proton magnetic resonance spectroscopy studies on human brain myo-Inositol in hypoosmolarity and hepatic encephalopathy. Gastroenterology 1994; 107: 1475-1480
59. Videen JS, Michaelis T, Pinto P, Ross BD. Human cerebral osmolytes during chronic hyponatremia. J Clin Invest 1995; 95: 788-793
60. Lee JH, Arcinue E, Ross BD. Brief report: Organic osmolytes in the brain of an infant with hypernatremia. N Engl J Med 1994; 331: 439-442
61. Frahm J, Michaelis T, Merboldt KD, Hänicke W, Gyngell M, Chien D, Bruhn H. Localized NMR spectroscopy in vivo. Progress and Problems. NMR in biomedicine 1989; 2: 188-195